Table 2.
Performance of the two-gene signature classifying the samples from validation datasets.
| Accession number | Symptomatology | Tissue | Biomarkers | AUC |
|---|---|---|---|---|
| GSE17718 | Control | CD4+ Lymphocyte | CD40LG and GBP2 | 1.00 |
| ATLL | Cell lines StEd and MT-2 | CD40LG and GBP2 | 1.00 | |
| GSE6034 | Control | CD4+ Lymphocyte | CD40LG and GBP2 | 1.00 |
| ATLL | Cell lines TaY, MT-2 and MT-4 | CD40LG and GBP2 | 1.00 | |
| GSE38537 | Control | CD4+ Lymphocyte | CD40LG and GBP2 | 1.00 |
| HAM/TSP | CD4+ Lymphocyte | CD40LG and GBP2 | 1.00 | |
| GSE33615 | Control | CD4+ Lymphocyte | CD40LG and GBP2 | 1.00 |
| ATLL | PBMCs (Mostly CD4+ Lymphocytes) | CD40LG and GBP2 | 1.00 | |
| GSE19080 | Control | CD4+ Lymphocyte | GBP2 | 0.87 |
| ATLL | CD4+ Lymphocyte | GBP2 | 0.50 | |
| HAM/TSP | CD4+ Lymphocyte | GBP2 | 0.66 | |
| GSE57259 | Control | CD4+ CD25+ CCR4+ Lymphocytes | CD40LG and GBP2 | 1.00 |
| HAM/TSP | CD4+ CD25+ CCR4+ Lymphocytes | CD40LG and GBP2 | 1.00 | |
| ATLL | CD4+ CD25+ CCR4+ Lymphocytes | CD40LG and GBP2 | 1.00 |